Skip to content

Head Fiation Device (Hfd 100)

by Imris, Inc. 510(k)

Active United States Open recall

510(k) K103493

Regulatory status

as of 29 Oct 2026

Recall ongoing. 1 ongoing FDA recall names this device. See recalls

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK103493 Date11 Mar 2011ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

3 recalls · 1 ongoing · FDA

    • Ongoing Z-1034-2026 FDA Class II initiated 8 Dec 2025

    Torque screw may crack or separate. If used, an affected screw could lead to inadequate head stabilization, compromised surgical precision, procedural delays, requirement for alternate head fixation methods, and risk of patient injury.

    • Terminated Z-0934-2022 FDA Class II initiated 17 Feb 2022

    Reports have been received that after normal or routine lateral forces are applied to the head fixation device, the split block clamp may deflect (rotationally around the axis) and not return to within acceptable distance from its prior position after the force is removed. In order to reduce deflection at the table mount location, users have tightened the hand knob screw to a degree that it is then difficult to untighten it later in the clinical workflow. Rotational movement at the table attachment point could result in HFD movement going unnoticed, which could result in a situation where surgical or medical intervention is necessary, a situation where navigation needs to be reestablished, or a situation resulting in extended time under anesthesia for the patient. It may also be difficult to loosen the mount clamp component after use, potentially leading to ergonomic injury or a workaround during equipment teardown.

    • Terminated Z-3211-2017 FDA Class II initiated 14 Aug 2017

    incorrect thread on thumbscrews

Specification

510(k)

510(k) Number
FDA Product Code
HBL
Device Class
Class II
Regulation
21 CFR Part 882.4460
Advisory Committee
Neurology
FDA Decision
SESE Substantially Equivalent

Other devices from Imris, Inc.

See all devices from Imris, Inc. →